Rigel Pharmaceuticals Market Cap

Rigel Pharmaceuticals has a market cap or net worth of $378.72 million as of June 12, 2025. Its market cap has increased by 137.89% in one year.

Market Cap

378.72M

Enterprise Value

402.66M

1-Year Change

137.89%

Ranking

#3145

Market Cap Chart

Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $378.72M, an increase of 48.57%. That is a compound annual growth rate of 1.63%.

Market Cap History

Date	Market Cap	% Change
Jun 11, 2025	378.70M	27.81%
Dec 31, 2024	296.30M	17.21%
Dec 29, 2023	252.80M	-2.51%
Dec 30, 2022	259.30M	-42.78%
Dec 31, 2021	453.20M	-23.37%
Dec 31, 2020	591.40M	64.87%
Dec 31, 2019	358.70M	-6.42%
Dec 31, 2018	383.30M	-32.57%
Dec 29, 2017	568.40M	141.36%
Dec 30, 2016	235.50M	-12.19%
Dec 31, 2015	268.20M	34.57%
Dec 31, 2014	199.30M	-20.02%
Dec 31, 2013	249.20M	-55.93%
Dec 31, 2012	565.50M	0.60%
Dec 30, 2011	562.10M	43.14%
Dec 31, 2010	392.70M	-20.31%
Dec 31, 2009	492.80M	68.36%
Dec 31, 2008	292.70M	-62.86%
Dec 31, 2007	788.20M	164.67%
Dec 29, 2006	297.80M	47.43%
Dec 30, 2005	202.00M	-57.71%
Dec 31, 2004	477.70M	68.26%
Dec 31, 2003	283.90M	465.54%
Dec 31, 2002	50.20M	-71.28%
Dec 31, 2001	174.80M	-51.24%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	694.24B
Johnson & Johnson	372.46B
AbbVie	335.65B
Novo Nordisk	332.47B
UnitedHealth Group	274.77B
Novartis AG	231.17B
Abbott Laboratories	229.81B
AstraZeneca	226.14B

Market Cap Rankings